Cencora stock holds firm after August 5 earnings beat
Published on 08/26/2026 at 22:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cencora Inc. (ISIN US15135B1017) reported $4.48 in adjusted earnings per share for the quarter ended August 5, 2026, above the $4.35 consensus estimate, and revenue reached $84.75 billion, up 5.1% from the prior year period.
The latest snapshot also points to a larger earnings base than last year, when quarterly EPS was $4.00, and the current-year analyst view in the same source set calls for $17.87 in EPS for fiscal 2026. That gap matters for a distributor whose margins are still measured in basis points.
Earnings power
On the bottom line, net margin was 0.79% and return on equity reached 125.45% in the most recent quarterly report, while the same period delivered revenue that exceeded the $84.31 billion estimate by $440 million.
The market cap now stands at $62.65 billion, with the shares opening at $328.28 on August 26, 2026 and a P/E ratio of 24.39. That combination leaves the stock priced for stable execution rather than for a step change in growth.
Dividend and positioning
Cencora declared a quarterly dividend of $0.60 per share, equal to $2.40 annualized, with payment set for August 31, 2026. Analysts in the source set also point to a consensus target of $370.85, which sits above the latest trading level.
For investors, the main issue is whether the company can keep turning a 5.1% revenue rise into steadier profit growth while preserving its dividend rhythm.
Distribution business
Cencora is a pharmaceutical distributor, so its model depends on scale, purchase terms and the speed of inventory turnover rather than on wide operating margins. The August 5 report showed how much value can still come from modest percentage changes in revenue and EPS.
Share level
Cencora stock traded at $328.28 as of August 26, 2026.
Fact box
Company: Cencora Inc.
ISIN: US15135B1017
Ticker: COR
Exchange: NYSE
Price (as of August 26, 2026, 9:30 a.m. ET): $328.28 USD
Market cap: $62.65 billion
Sector / Industry: Health Care / Health Care Distributors
Index membership: S&P 500
Next earnings date: November 2026
